Slc25a46 | solute carrier family 25, member 46
Physiological systems
17 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological
15 No significant impact
7 Not tested
Data collections
Gene metrics:3Significant phenotypes
4Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
increased circulating glucose level | 1 supporting dataset | Slc25a46em1(IMPC)J | heterozygote | Early adult | 9.97x10-6 | ||
increased fasting circulating glucose level | 1 supporting dataset | Slc25a46em1(IMPC)J | heterozygote | Early adult | 4.07x10-6 | ||
decreased grip strength | 2 supporting datasets | Slc25a46em1(IMPC)J | heterozygote | Early adult | 4.98x10-6 |
| | | | | | | | | |
External links
No external links available for Slc25a46.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Slc25a46em1(IMPC)J | Exon Deletion | | mouse |
Slc25a46tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Slc25a46tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |